About Deep Knowledge Ventures
Deep Knowledge Ventures is a venture capital firm founded in 2014. It is primarily based out of San Francisco, United States. As of Mar 2015, Deep Knowledge Ventures has invested in 5 companies. It primarily invests in Seed round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Grant (prize money) round of In Silico Overall, Deep Knowledge Ventures portfolio has seen 1 IPO, namely In Silico. Deep Knowledge Ventures has team of 4 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed
Portfolio IPOs
Deep Knowledge Ventures' List of All Investments
Deep Knowledge Ventures has a portfolio of 5 companies. Their most notable investmentis in In SilicoTheir portfolio spans across United States, Canada and China. They have invested in Life Sciences, High Tech, Enterprise Applications and 2 other sectors, across stages such as Seed stage. Here is the list of all investments by Deep Knowledge Ventures:
1. In Silico
AI-enabled bioinformatics platform for drug discovery and biomarker development. The company provides solutions and services such as custom drug discovery engines, biomarker discovery, and aging research tools to academia, pharmaceutical, and cosmetics companies. Also, it has developed a product PHARMA.AI which includes modules for drug discovery such as PandaOmics, Chemistry42, and InClinico.
Key facts about In Silico
- Founded Year: 2014
- Location: Cambridge (United States)
- Stage: Public
- Total Funding till date: $510M
- Employee Count: 283 as on Mar 31, 2026
- Investors: Deerfield, BHR and 36 Others
- Latest Funding Round: Series E, Jan 07, 2025, $*****
- Highlight: Public
Pathway Pharmaceuticals offers the proprietary OncoFinder platform. The OncoFinder predicts efficacy of approved drugs on different tumor types by comparing cancerous gene expression with gene expression in a cohort of healthy individuals. Pathway offers OncoFinder as a service to pharmaceutical and healthcare companies, where they can use it to tailor therapies for patients or to tailor drug pipelines for the most efficient targets.
Key facts about Pathway Pharmaceuticals
- Founded Year: 2006
- Location: Hong Kong (China)
- Stage: Deadpooled
- Employee Count: 11 - 50 as on Jul 01, 2024
- Investors: Deep Knowledge Ventures and Deep Knowledge Life Sciences
- Latest Funding Round: Seed, Dec 16, 2015, $*****
Vision Genomics develops therapeutic solutions for ophthalmic disorders. Its drug discovery platform uses an integrated genomic and transcriptomic approach to identify drug targets. The platform uses proprietary big data algorithms in combination with machine learning to identify viable drug candidates for the targets. First application is age-related macular degeneration.
Key facts about Vision Genomics
- Founded Year: 2014
- Location: Washington, DC (United States)
- Stage: Deadpooled
- Employee Count: 1 as on Mar 31, 2026
- Investors: Deep Knowledge Ventures and Deep Knowledge Life Sciences
_1533875468106.png?format=webp&height=120&width=120){kind=logo}
Developer of bioinformatics solutions for regenerative medicine. The company is providing regenerative medicine, stem cell research, and anti-aging therapies. Also, the company screens drugs in silico for drug repositioning.
Key facts about Atlas Regeneration
- Founded Year: 2015
- Location: Winston-salem (United States)
- Stage: Deadpooled
- Investors: Deep Knowledge Ventures
5. CCARL
Key facts about CCARL
- Founded Year: 2014
- Location: Lethbridge (Canada)
- Stage: Deadpooled
- Investors: Deep Knowledge Ventures
Deep Knowledge Ventures' Investments by Stage
Deep Knowledge Ventures has made 2 investments in Seed stage.Deep Knowledge Ventures' Investments by Sector
Deep Knowledge Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Life Sciences, Artificial Intelligence - Industry Applications and HealthTech. Notably, it has invested in 4 Tech companies, 3 Enterprise (B2B) companies, 3 Software companies and 1 company focusing on AI-Native.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
High Tech | 2 |
Life Sciences | 2 |
Artificial Intelligence - Industry Applications | 1 |
HealthTech | 1 |
Note: We have considered here, only first round of investments
Deep Knowledge Ventures' Investments by Geography
Deep Knowledge Ventures has made most investments in China (1), followed by United States where it has made 1 investment.Deep Knowledge Ventures' recent investments
Deep Knowledge Ventures has not made any investment in 2026 so far.Here are the most recent investments by Deep Knowledge Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 15, 2015 | United States | Grant (prize money) | 4395 | - | |
Apr 16, 2014 | United States | Seed | 7339 | - | |
Apr 14, 2014 | China | Seed | 5657 | - |
IPOs and Publicly Listed companies in Deep Knowledge Ventures' Portfolio
1 of Deep Knowledge Ventures' portfolio company became public - In Silico. It got listed on the Hong Kong Exchanges (HKG), in Dec 2025 at marketcap of $1.72BHere are Deep Knowledge Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 30, 2025 | Apr 16, 2014 | Seed | 5931 |
Team profile of Deep Knowledge Ventures
Deep Knowledge Ventures has a team of 4 members including 2 Partners located in United Kingdom and United Arab Emirates. Deep Knowledge Ventures' team does not sit on the board of any company as of now.Co-investors of Deep Knowledge Ventures
Over the past 12 years, 29 investors have co-invested in Deep Knowledge Ventures's portfolio companies. This includes funds and angels.
- Invested before Deep Knowledge Ventures: HHS has invested before Deep Knowledge Ventures.
- Invested after Deep Knowledge Ventures: A total of 28 investors have invested in Deep Knowledge Ventures's portfolio after their investments. Top Investors include Prosperity7 Ventures (1 company), Qiming Venture Partners (1 company) and BHR (1 company).
